Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.58 |
| ▸ | RECQL | P46063 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | THRB | P10828 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | SNCA | P37840 | 2/20 | 0.58 |
| ▸ | APP | P05067 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | CASP1 | P29466 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.48 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.48 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.48 |
| ▸ | CDK2 | P24941 | 5/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31037128 | 1.00 | HPGD (0.58) | HPGDALOX15RECQLHSD17B10TDP1 | |
| SCHEMBL18068458 | 0.84 | HPGD (0.56) | HPGDALOX15RECQLHSD17B10TDP1 | |
| SCHEMBL13300910 | 0.83 | MAPT (0.56) | HPGDALOX15RECQLHSD17B10TDP1 | |
| SCHEMBL3220975 | 0.81 | HPGD (0.58) | HPGDALOX15RECQLHSD17B10TDP1 | |
| SCHEMBL7301115 | 0.80 | HPGD (0.46) | HPGDALOX15RECQLHSD17B10TDP1 | |
| SCHEMBL18716074 | 0.79 | HPGD (0.62) | HPGDALOX15RECQLHSD17B10TDP1 | |
| SCHEMBL7302249 | 0.77 | MAPT (0.54) | HPGDALOX15RECQLHSD17B10TDP1 | |
| SCHEMBL31256488 | 0.77 | HPGD (0.59) | HPGDALOX15RECQLHSD17B10TDP1 | |
| SCHEMBL18716135 | 0.77 | HPGD (0.59) | HPGDALOX15RECQLHSD17B10TDP1 | |
| SCHEMBL5518010 | 0.76 | HPGD (0.52) | HPGDALOX15RECQLHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190337966-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | OSAKA UNIVERSITY (JP) | 2019-11-07 | — | — | US | disclosed |
| EP-3564245-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | Osaka University (JP) | 2019-11-06 | — | — | EP | disclosed |
| WO-2018123207-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | 国立大学法人大阪大学 | 2018-07-05 | — | — | WO | disclosed |
| EP-1454919-B2 | SCALE DEPOSIT INHIBITOR, PROCESS FOR ITS PRODUCTION, POLYMERIZER WHOSE INSIDE WALL IS COVERED WITH THE INHIBITOR, AND PROCESS FOR PRODUCTION OF VINYLIC POLYMERS BY THE USE OF THE POLYMERIZER | TOKUYAMA CORP (JP) | 2012-10-31 | — | — | EP | disclosed |
| EP-1454919-B1 | SCALE DEPOSIT INHIBITOR, PROCESS FOR ITS PRODUCTION, POLYMERIZER WHOSE INSIDE WALL IS COVERED WITH THE INHIBITOR, AND PROCESS FOR PRODUCTION OF VINYLIC POLYMERS BY THE USE OF THE POLYMERIZER | TOKUYAMA CORP (JP) | 2008-06-18 | — | — | EP | disclosed |
| US-6894125-B2 | Scale deposit inhibitor, process for its production, polymerizer whose inside wall is covered with the inhibitor, and process for production of vinylic polymers by the use of the polymerizer | TOKUYAMA CORPORATION (JP) | 2005-05-17 | — | — | US | disclosed |
| EP-1454919-A1 | SCALE DEPOSIT INHIBITOR, PROCESS FOR ITS PRODUCTION, POLYMERIZER WHOSE INSIDE WALL IS COVERED WITH THE INHIBITOR, AND PROCESS FOR PRODUCTION OF VINYLIC POLYMERS BY THE USE OF THE POLYMERIZER | Tokuyama Corporation (JP) | 2004-09-08 | — | — | EP | disclosed |
| US-20040077804-A1 | Scale deposit inhibitor, process for its production, polymerizer whose inside wall is covered with the inhibitor, and process for production of vinylic polymers by the use of the polymerizer | TOKUYAMA CORPORATION (JP) | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190337966-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | CYP24A1, CYP26B1, CYP21A2 | HPGD 815/4885ALOX15 2174/4885RECQL 2140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.